FIME Q3 2024 Earnings Presentation FMC CORPORATION 1 An Agricultural Sciences Company Q3 2024 Earnings Presentation October 30, 2024 Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements made in this presentation are forwardlooking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. In some cases, you can ...

Financial Data and Key Metrics Changes - The company reported a sales growth of 9% in Q3 2024, with organic sales growth of 12% and volume growth of 17% [18][22] - Adjusted EBITDA grew 15% year-over-year, exceeding the high end of guidance [22] - Free cash flow in Q3 was $132 million, an improvement of $100 million compared to the prior year [31] Business Line Data and Key Metrics Changes - Sales of diamide products increased by 58% compared to the prior year, with strong performance across all regions [11] - New products, particularly fluindapyr and Isoflex-based products, are expected to generate over $100 million in sales in the second half of the year [12] - Insecticides in North America saw significantly higher sales due to increased orders from diamide products [19] Market Data and Key Metrics Changes - North America sales increased by 48%, driven by strong volume growth [19] - Latin America sales grew by 8%, with 15% growth excluding currency effects, despite challenges in Brazil and Argentina [19] - Asia experienced a 10% sales decline, primarily due to lower sales in India [21] Company Strategy and Development Direction - The company is focusing on maintaining market share in Latin America despite pricing pressures, with a strategy to protect market position [9][14] - Cost savings from restructuring are targeted at $125 million to $150 million for 2024, with a gross run rate of over $225 million in 2025 [16][24] - The company plans to introduce four new active ingredients and develop a post-pattern defense strategy for diamides [34] Management's Comments on Operating Environment and Future Outlook - Management noted that while Latin America faced unexpected challenges, North America performed stronger than anticipated [7][10] - The company expects channel inventory recoveries to improve in the U.S. and Europe by the end of Q1 2025, while Asia may not recover until 2026 [15] - Management remains confident in achieving full-year guidance despite ongoing challenges in certain markets [17] Other Important Information - The company confirmed the sale of its Global Specialty Solutions business for $350 million, expected to close in early November [24] - The effective tax rate for adjusted earnings for 2024 has been lowered to a range of 13% to 15% [28] Q&A Session Summary Question: Update on 2025 revenue growth expectations - Management reiterated a target of around 6% revenue growth for 2025, with potential for higher cost savings [36][37] Question: Conditions in Latin America - Management acknowledged that Q3 was more challenging than expected due to weather and market conditions, but noted improvements in Q4 [40][41] Question: Forward pricing trajectory - Management indicated that pricing pressure is correlated with market conditions, with diamides showing less pressure compared to other products [43][45] Question: Volume gains in North America - Growth to diamide partners accounted for more than half of the growth, with all sales directed to wholesalers [47] Question: R&D spending approach - Management clarified that R&D cost reductions are sustainable and will not impact the launch of new products [49][51] Question: Visibility on new product orders - Approximately 40% of forecasted orders for Q4 have been secured in Brazil, indicating a recovering market [65] Question: Pricing challenges in Latin America - Management expects mid-single-digit price decreases in Q4, with pricing pressure likely to persist into 2025 [79][80]

FMC Corporation (FMC) logged earnings of 52 cents per share in third-quarter 2024. This compares favorably with a loss of 3 cents in the year-ago quarter. Barring one-time items, adjusted earnings per share were 69 cents, topping the Zacks Consensus Estimate of 49 cents. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. Revenues were $1,065.4 million, up around 9% from the year-ago quarter's level. The top line surpassed the Zacks Consensus Estimate of $1,030.5 million. The top line in ...

FMC (FMC) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.44 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 40.82%. A quarter ago, it was expected that this chemical producer would post earnings of $0.50 per share when it actually produced earnings of $0.63, delivering a surprise of 26%. Over the last four quarters, the company has s ...

Exhibit 99.1 FMC Corporation 2929 Walnut Street Philadelphia, PA 19104 USA News Release 215.299.6000 fmc.com For Release: Immediate Media contact: Nicole Canning +1.215.299.5916 Nicole.Canning@fmc.com Investor Contact: Curt Brooks +1.215.299.6137 Curt.Brooks@fmc.com FMC Corporation reports strong growth in third quarter, confirms full-year outlook adjusted for expected sale of GSS business Volume growth and higher cost savings led to earnings above the high end of guidance range Third Quarter 2024 Highlight ...

Volume growth and higher cost savings led to earnings above the high end of guidance range Third Quarter Adjusted EPS versus Prior-Year Quarter +25 cents Adjusted EBITDA +18 cents Interest Expense +4 cents Depreciation & Amortization +2 cents Minority Interest -1 cent Taxes +3 cents Rounding -1 cent FMC Revenue Q3 2024 Total Revenue Change (GAAP) 9 % Less FX Impact (3) % Organic1 Revenue Change (Non-GAAP) 12 % Third Quarter 2024 Highlights Revenue of $1.07 billion, an increase of 9 percent versus Q3 2023 an ...

FMC Corporation (FMC) is set to release third-quarter 2024 results after the closing bell on Oct. 29.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The company beat the Zacks Consensus Estimate for earnings in two of the last four quarters and missed twice. On average, FMC has a trailing four-quarter earnings surprise of around 6.2%. The company reported an earnings surprise of 26% in the last reported quarter.FMC is likely to have faced challenges from pricing pressure and signifi ...

FMC Corporation (FMC) is benefiting from efforts to expand its product portfolio through new product launches and its restructuring actions. FMC, which is among the prominent players in the chemical space along with Dow Inc. (DOW) , Celanese Corporation (CE) and Air Products and Chemicals, Inc. (APD) , delivered better-than-expected results in the second quarter on the back of higher volumes. It saw improved demand in the quarter, leading to an increase in sales volumes, especially in the United States and ...

For Immediate ReleaseChicago, IL – October 9, 2024 – Today, Zacks Equity Research DuPont de Nemours, Inc. (DD) , FMC Corp. (FMC) and Cabot Corp. (CBT) .Industry: Chemicals - DiversifiedLink: https://www.zacks.com/commentary/2347240/3-diversified-chemical-stocks-to-escape-industry-challengesThe Zacks Chemicals Diversified industry is plagued by sluggish demand in certain markets, including consumer durables and building & construction, and some residual impacts of consumer inventory destocking. Lower consume ...

Here are three stocks with buy rank and strong income characteristics for investors to consider today, October 8th:MPLX LP (MPLX) : This master limited partnership (MLP) company which is engaged in providing a wide range of midstream energy services, including fuel distribution solutions, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.7% over the last 60 days.This Zacks Rank #1 (Strong Buy) company has a dividend yield of 7.6%, compared with the industry average of 4.6 ...